T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling-Reference-Cited by-同舟云学术

T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling

Published:2014-06 Issue:25 Volume:289 Page:17647-17657
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Li Man,Xia Pengyan,Du Ying,Liu Shengwu,Huang Guanling,Chen Jun,Zhang Honglian,Hou Ning,Cheng Xuan,Zhou Luyu,Li Peifeng,Yang Xiao,Fan Zusen

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference50 articles.

1. Functions of natural killer cells;Vivier;Nat. Immunol,2008

2. Adaptive immune features of natural killer cells;Sun;Nature,2009

3. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors;Fan;Blood,2006

4. Activation, coactivation, and costimulation of resting human natural killer cells;Bryceson;Immunol. Rev,2006

5. Regulation of ligands for the NKG2D activating receptor;Raulet;Annu. Rev. Immunol,2013

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape;Frontiers in Immunology;2024-09-13

2. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

3. Surface Immune Checkpoints as Potential Biomarkers in Physiological Pregnancy and Recurrent Pregnancy Loss;International Journal of Molecular Sciences;2024-08-29

4. Target therapy of TIGIT; a novel approach of immunotherapy for the treatment of colorectal cancer;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-19

5. The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy;Frontiers in Immunology;2024-08-02